WIJNGAARD PETER purchased 111.1% of their position (5K shares) of HEPION PHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $15.3K — a major conviction buy. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 11/28/2023ACC: 0001104659-23-121427
Director
Since Jun 2020
+5K
Net shares
Net buyer
$15.3K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
5K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+2.50K
Price / share
$3.09
Trade value
$7.72K
% of position
55.5%
11/24/2023
4.50K→7K
Common Stock
Direct
Shares
+2.50K
Price / share
$3.05
Trade value
$7.63K
% of position
35.7%
11/27/2023
7K→9.50K
Total
Net shares
+5K
Net value
$15.35K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/24/2023 | P · Purchase | +2.50K | $3.09 | $7.72K | 55.5% | 4.50K | 7K |
| Common Stock Direct | 11/27/2023 | P · Purchase | +2.50K | $3.05 | $7.63K | 35.7% | 7K | 9.50K |
| Total | +5K | $15.35K | ||||||
Derivative Transactions0
No derivative transactions reported